key: cord-0793106-pj5v1ne3
authors: Chua, Kao-Ping; Conti, Rena M.; Becker, Nora V.
title: Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020
date: 2021-10-18
journal: JAMA Netw Open
DOI: 10.1001/jamanetworkopen.2021.29894
sha: 78bf6de1f3be3687d453f96dbec452fc15b9351f
doc_id: 793106
cord_uid: pj5v1ne3

IMPORTANCE: Many insurers waived cost sharing for COVID-19 hospitalizations during 2020. Nonetheless, patients may have been billed if their plans did not implement waivers or if waivers did not capture all hospitalization-related care. Assessment of out-of-pocket spending for COVID-19 hospitalizations in 2020 may show the financial burden that patients may experience if insurers allow waivers to expire, as many chose to do during 2021. OBJECTIVE: To estimate out-of-pocket spending for COVID-19 hospitalizations in the US in 2020. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the IQVIA PharMetrics Plus for Academics Database, a national claims database representing 7.7 million privately insured patients and 1.0 million Medicare Advantage patients, regarding COVID-19 hospitalizations for privately insured and Medicare Advantage patients from March to September 2020. MAIN OUTCOMES AND MEASURES: Mean total out-of-pocket spending, defined as the sum of out-of-pocket spending for facility services billed by hospitals (eg, accommodation charges) and professional and ancillary services billed by clinicians and ancillary providers (eg, clinician inpatient evaluation and management, ambulance transport). RESULTS: Analyses included 4075 hospitalizations; 2091 (51.3%) were for male patients, and the mean (SD) age of patients was 66.8 (14.8) years. Of these hospitalizations, 1377 (33.8%) were for privately insured patients. Out-of-pocket spending for facility services, professional and ancillary services, or both was reported for 981 of 1377 hospitalizations for privately insured patients (71.2%) and 1324 of 2968 hospitalizations for Medicare Advantage patients (49.1%). Among these hospitalizations, mean (SD) total out-of-pocket spending was $788 ($1411) for privately insured patients and $277 ($363) for Medicare Advantage patients. In contrast, out-of-pocket spending for facility services was reported for 63 hospitalizations for privately insured patients (4.6%) and 36 hospitalizations for Medicare Advantage patients (1.3%). Among these hospitalizations, mean (SD) total out-of-pocket spending was $3840 ($3186) for privately insured patients and $1536 ($1402) for Medicare Advantage patients. Total out-of-pocket spending exceeded $4000 for 2.5% of privately insured hospitalizations compared with 0.2% of Medicare Advantage hospitalizations. CONCLUSIONS AND RELEVANCE: In this cross-sectional study, few patients hospitalized for COVID-19 in 2020 were billed for facility services provided by hospitals, suggesting that most were covered by insurers with cost-sharing waivers. However, many patients were billed for professional and ancillary services, suggesting that insurer cost-sharing waivers may not have covered all hospitalization-related care. High cost sharing for patients who were billed by facility services suggests that out-of-pocket spending may be substantial for patients whose insurers have allowed waivers to expire.

eAppendix 1. Rationale for including hospitalizations with admission and discharge date before instead of through September 30, 2020

Our claims database was considered to be complete through September 30, 2020 at the time we received the data at the end of March 2021. In our database, confinement episodes are defined as a contiguous string of facility room and board claims from the same billing identifier. The first and last dates of this string are the admission and discharge dates, respectively. If this string ends on September 29, 2020, we could be confident there was not another facility room and board claim on September 30, 2020, owing to the completeness of the data. However, if a string includes September 30, 2020, we cannot be sure that there were no other facility room and board claims on October 1, 2020. Thus, we required that the discharge date (last facility room and board claim) be on or before September 29, 2020.

Facility claims were institutional claims with place of service code 21 (hospital) or 23 (emergency department) in which the "billing specialty" variable corresponded to a hospital. These included inpatient hospital services such as room and board, pharmacy, IV therapy, supplies, laboratory, radiology, blood bank, respiratory services, physical/occupational/speech therapy, and inpatient dialysis. These also included facility charges for emergency departments (e.g., revenue codes 0450-0459).

Professional/ancillary claims were defined as one of the following 3 mutually exclusive types of claims:

1) Ambulance claims -place of service code 41-42 (ambulance) OR HCPCS codes between A0000-A9999 2) Clinician claims: (place of service 21 or 23) AND billing specialty variable = clinician 3) Miscellaneous claims: (place of service 21 or 23) AND billing specialty variable = other (including durable medical equipment providers and other facilities, such as dialysis centers)

The four subtypes of clinician claims were defined as follows:

1) Emergency department claims -place of service code 23 AND billing specialty variable = clinician 2) Inpatient evaluation and management claimsplace of service code 21 (hospital) AND billing specialty variable = clinician AND procedure codes for clinician services such as initial and subsequent hospital care or hospital discharge services: 99217, 99218, 99219, 99220, 99221, 99222, 99223, 99224, 99225, 99226, 99231, 99232, 99233, 99234, 99235, 99236, 99238, 99239, 99251, 99252, 99253, 99254, 99255, 99291, 99292, 99356, 99357, 99358, 99359, 99360, 99366, 99367, 99368, 99460, 99461, 99462, 99463, 99464, 99465, 99466, 99467, 99468, 99469, 99471, 99472, 99475, 99476, 99477, 99478, 99479, 99480, 99485, 99486, 99487, 99489, 99490, 99491, 99497, 99498, 99499, G0378, G0379, G0390 3) Inpatient diagnostic claims: place of service code 21 (hospital) AND billing specialty variable = clinician AND CPT/HCPCS codes that were a) between 70000-79999 (radiology); b) between 80000-89999 or U0001-U0004 (laboratory tests); or c) CPT codes for the following types of tests: Limited bilateral noninvasive physiologic studies of upper or lower extremity arteries, (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus bidirectional, Doppler waveform recording and analysis at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus volume plethysmography at 1-2 levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries with, transcutaneous oxygen tension measurement at 1-2 levels) 93923

Complete bilateral noninvasive physiologic studies of upper or lower extremity arteries, 3 or more levels (eg, for lower extremity: ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental blood pressure measurements with bidirectional Doppler waveform recording and analysis, at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental volume plethysmography at 3 or more levels, or ankle/brachial indices at distal posterior tibial and anterior tibial/dorsalis pedis arteries plus segmental transcutaneous oxygen tension measurements at 3 or more levels), or single level study with provocative functional maneuvers (eg, measurements with postural provocative tests, or measurements with reactive hyperemia) 93924

Noninvasive physiologic studies of lower extremity arteries, at rest and following treadmill stress testing, (ie, bidirectional Doppler waveform or volume plethysmography recording and analysis at rest with ankle/brachial indices immediately after and at timed intervals following performance of a standardized protocol on a motorized treadmill plus recording of time of onset of claudication or other symptoms, maximal walking time, and time to recovery) complete bilateral study 93925

Duplex scan of lower extremity arteries or arterial bypass grafts; complete bilateral study Transesophageal echocardiography for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report 93316

Transesophageal echocardiography for congenital cardiac anomalies; placement of transesophageal probe only 93317

Transesophageal echocardiography for congenital cardiac anomalies; image acquisition, interpretation and report only 93318

Echocardiography, transesophageal (TEE) for monitoring purposes, including probe placement, real time 2dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis 93320

Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); complete 93321

Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging) 93325

Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) 93350

Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; 93351

Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional 93352

Use of echocardiographic contrast agent during stress echocardiography (List separately in addition to code for primary procedure) 93355

Echocardiography, transesophageal (TEE) for guidance of a transcatheter intracardiac or great vessel(s) structural intervention(s) (eg,TAVR, transcatheter pulmonary valve replacement, mitral valve repair, paravalvular regurgitation repair, left atrial appendage occlusion/closure, ventricular septal defect closure) (peri-and intra-procedural), real-time image acquisition and documentation, guidance with quantitative measurements, probe manipulation, interpretation, and report, including diagnostic transesophageal echocardiography and, when performed, administration of ultrasound contrast, Doppler, color flow, and 3D Electroencephalography Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; without video 95720

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) 95721

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, without video 95722

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 36 hours, up to 60 hours of EEG recording, with video (VEEG) 95723

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, without video 95724

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 60 hours, up to 84 hours of EEG recording, with video (VEEG)

facility or professional/ancillary service, the proportion of hospitalizations for privately insured and Medicare Advantage patients with out-of-pocket spending for any associated claim was 73.6% and 53.8%. These proportions were similar to the proportion of hospitalizations with out-ofpocket spending for facility services, professional/ancillary services

Incidence of cost-sharing for facility services among hospitalizations for patients in the lowest quartile of out-of-pocket spending prior to hospitalization This analysis subset to 3,617 COVID-19 hospitalizations with continuous enrollment between

Among hospitalizations for privately insured patients and Medicare Advantage patients in the lowest quartile, 8.3% and 1.8% had cost-sharing for facility claims. Findings suggests that cost-sharing waivers, rather than patients meeting out-of-pocket maximums

Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, without video 95726Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, interpretation, and summary report, complete study; greater than 84 hours of EEG recording, with video (VEEG) 4) Other inpatient services, defined as claims with place of service code 21 and billing specialty type = clinician AND procedure codes that were not related to inpatient evaluation and management or diagnostic testing (e.g., anesthesia, surgery, dialysis, and intubation).

Intensive care utilization was defined based on revenue codes 0200-0209 (intensive care unit) and revenue codes 0210-0219 (coronary care unit)